Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with TCAs (moderate certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with pramipexole (low certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with reboxetine (moderate certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with agomelatine (low certainty).
Fluoxetine probably leads to higher failure to respond (reduction ≥ 50% on HDRS) compared with sertraline (moderate certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with tianeptine (moderate certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with trazodone (moderate certainty).
Fluoxetine probably leads to higher failure to respond (reduction ≥ 50% on HDRS) compared with venlafaxine (moderate certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with amineptine (moderate certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with bupropion (moderate certainty).
It is very uncertain whether fluoxetine changes failure to respond (reduction ≥ 50% on HDRS) compared with citalopram (very low certainty).
It is very uncertain whether fluoxetine changes failure to respond (reduction ≥ 50% on HDRS) compared with crocus sativus (very low certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with duloxetine (low certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with escitalopram (low certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with fluvoxamine (low certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with hypericum (moderate certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with maprotiline (moderate certainty).
It is very uncertain whether fluoxetine changes failure to respond (reduction ≥ 50% on HDRS) compared with mianserin (very low certainty).